Trial intelligence / Profile preview

Intranasal vs Intravenous Ketamine for Procedural Sedation in Children (INK)

NCT02828566Phase 3Unknown

Start
Oct 2017
Primary completion
Jan 2019
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial of ketamine in bone fracture (Fx) and Dislocation (2 arms). Primary endpoint: Adequacy of sedation. Status: unknown.

02

Drugs

ketamine
03

Conditions

bone fracture (Fx)Dislocation

Beyond the preview

Go deeper on NCT02828566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02828566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call